APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Full Body Exoskeleton

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Full Body Exoskeleton Market Outlook and Growth Opportunities 2026

Report ID 17378745043 May 2026193 pages

Choose your research edition.

Industry ResearchFull Body Exoskeleton Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Full Body Exoskeleton Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Full Body Exoskeleton Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Full Body Exoskeleton Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Full Body Exoskeleton Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Full Body Exoskeleton market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Full Body Exoskeleton is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Full Body Exoskeleton is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Full Body Exoskeleton is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Full Body Exoskeleton market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Full Body Exoskeleton market include Suit X, Cyberdyne, B-Temia, Wandercraft, ExoAtlet, Ekso Bionics, ReWalk Robotics, Parker Hannifin and Bionik Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Full Body Exoskeleton market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Full Body Exoskeleton and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Full Body Exoskeleton sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Full Body Exoskeleton market size, projected growth trends, production technologies, key applications, and end-use industries.

Full Body Exoskeleton Segment by Company

Suit X

Cyberdyne

B-Temia

Wandercraft

ExoAtlet

Ekso Bionics

ReWalk Robotics

Parker Hannifin

Bionik Laboratories

Rex Bionics

Full Body Exoskeleton Segment by Type

Rehabilitation Exoskeleton

Industrial Exoskeleton

Military and Defense Exoskeleton

Sports and Fitness Exoskeleton

Search and Rescue Exoskeleton

Full Body Exoskeleton Segment by Application

Rehabilitation

Assistive

Defense

Industrial

Other

Full Body Exoskeleton Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Full Body Exoskeleton status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Full Body Exoskeleton market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Full Body Exoskeleton significant trends, drivers, influence factors in global and regions.

6. To analyze Full Body Exoskeleton competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Full Body Exoskeleton market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Full Body Exoskeleton and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Full Body Exoskeleton.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Full Body Exoskeleton market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Full Body Exoskeleton industry.

Chapter 3: Detailed analysis of Full Body Exoskeleton manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Full Body Exoskeleton in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Full Body Exoskeleton in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Full Body Exoskeleton Industry Trends Table 2. Full Body Exoskeleton Industry Drivers Table 3. Full Body Exoskeleton Industry Opportunities and Challenges Table 4. Full Body Exoskeleton Industry Restraints Table 5. Global Full Body Exoskeleton Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Full Body Exoskeleton Revenue Share by Company (2021-2026) Table 7. Global Full Body Exoskeleton Sales Volume by Company (k units) & (2021-2026) Table 8. Global Full Body Exoskeleton Sales Volume Share by Company (2021-2026) Table 9. Global Full Body Exoskeleton Average Price (USD/unit) of Company (2021-2026) Table 10. Global Full Body Exoskeleton Company Ranking, (2024-2026) & (USD Million) Table 11. Global Full Body Exoskeleton Key Company Manufacturing Base & Headquarters Table 12. Global Full Body Exoskeleton Company, Product Type & Application Table 13. Global Full Body Exoskeleton Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Full Body Exoskeleton by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Rehabilitation Exoskeleton Table 18. Significant Companies of Industrial Exoskeleton Table 19. Significant Companies of Military and Defense Exoskeleton Table 20. Significant Companies of Sports and Fitness Exoskeleton Table 21. Significant Companies of Search and Rescue Exoskeleton Table 22. Global Full Body Exoskeleton Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global Full Body Exoskeleton Sales Volume by Type (2021-2026) & (k units) Table 24. Global Full Body Exoskeleton Sales Volume by Type (2027-2032) & (k units) Table 25. Global Full Body Exoskeleton Sales Volume Share by Type (2021-2026) Table 26. Global Full Body Exoskeleton Sales Volume Share by Type (2027-2032) Table 27. Global Full Body Exoskeleton Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Full Body Exoskeleton Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Full Body Exoskeleton Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Full Body Exoskeleton Sales Value Share by Type (2021-2026) Table 31. Global Full Body Exoskeleton Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Rehabilitation Table 33. Significant Companies of Assistive Table 34. Significant Companies of Defense Table 35. Significant Companies of Industrial Table 36. Significant Companies of Other Table 37. Global Full Body Exoskeleton Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Full Body Exoskeleton Sales Volume by Application (2021-2026) & (k units) Table 39. Global Full Body Exoskeleton Sales Volume by Application (2027-2032) & (k units) Table 40. Global Full Body Exoskeleton Sales Volume Share by Application (2021-2026) Table 41. Global Full Body Exoskeleton Sales Volume Share by Application (2027-2032) Table 42. Global Full Body Exoskeleton Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Full Body Exoskeleton Sales Value by Application (2021-2026) & (US$ Million) Table 44. Global Full Body Exoskeleton Sales Value by Application (2027-2032) & (US$ Million) Table 45. Global Full Body Exoskeleton Sales Value Share by Application (2021-2026) Table 46. Global Full Body Exoskeleton Sales Value Share by Application (2027-2032) Table 47. Global Full Body Exoskeleton Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 48. Global Full Body Exoskeleton Sales by Region (2021-2026) & (k units) Table 49. Global Full Body Exoskeleton Sales Market Share by Region (2021-2026) Table 50. Global Full Body Exoskeleton Sales by Region (2027-2032) & (k units) Table 51. Global Full Body Exoskeleton Sales Market Share by Region (2027-2032) Table 52. Global Full Body Exoskeleton Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Full Body Exoskeleton Sales Value by Region (2021-2026) & (US$ Million) Table 54. Global Full Body Exoskeleton Sales Value Share by Region (2021-2026) Table 55. Global Full Body Exoskeleton Sales Value by Region (2027-2032) & (US$ Million) Table 56. Global Full Body Exoskeleton Sales Value Share by Region (2027-2032) Table 57. Global Full Body Exoskeleton Market Average Price (USD/unit) by Region (2021-2026) Table 58. Global Full Body Exoskeleton Market Average Price (USD/unit) by Region (2027-2032) Table 59. Global Full Body Exoskeleton Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 60. Global Full Body Exoskeleton Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Full Body Exoskeleton Sales by Country (2021-2026) & (k units) Table 62. Global Full Body Exoskeleton Sales Market Share by Country (2021-2026) Table 63. Global Full Body Exoskeleton Sales by Country (2027-2032) & (k units) Table 64. Global Full Body Exoskeleton Sales Market Share by Country (2027-2032) Table 65. Global Full Body Exoskeleton Sales Value by Country (2021-2026) & (US$ Million) Table 66. Global Full Body Exoskeleton Sales Value Market Share by Country (2021-2026) Table 67. Global Full Body Exoskeleton Sales Value by Country (2027-2032) & (US$ Million) Table 68. Global Full Body Exoskeleton Sales Value Market Share by Country (2027-2032) Table 69. Suit X Company Information Table 70. Suit X Business Overview Table 71. Suit X Full Body Exoskeleton Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 72. Suit X Full Body Exoskeleton Product Portfolio Table 73. Suit X Recent Development Table 74. Cyberdyne Company Information Table 75. Cyberdyne Business Overview Table 76. Cyberdyne Full Body Exoskeleton Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 77. Cyberdyne Full Body Exoskeleton Product Portfolio Table 78. Cyberdyne Recent Development Table 79. B-Temia Company Information Table 80. B-Temia Business Overview Table 81. B-Temia Full Body Exoskeleton Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 82. B-Temia Full Body Exoskeleton Product Portfolio Table 83. B-Temia Recent Development Table 84. Wandercraft Company Information Table 85. Wandercraft Business Overview Table 86. Wandercraft Full Body Exoskeleton Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. Wandercraft Full Body Exoskeleton Product Portfolio Table 88. Wandercraft Recent Development Table 89. ExoAtlet Company Information Table 90. ExoAtlet Business Overview Table 91. ExoAtlet Full Body Exoskeleton Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. ExoAtlet Full Body Exoskeleton Product Portfolio Table 93. ExoAtlet Recent Development Table 94. Ekso Bionics Company Information Table 95. Ekso Bionics Business Overview Table 96. Ekso Bionics Full Body Exoskeleton Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Ekso Bionics Full Body Exoskeleton Product Portfolio Table 98. Ekso Bionics Recent Development Table 99. ReWalk Robotics Company Information Table 100. ReWalk Robotics Business Overview Table 101. ReWalk Robotics Full Body Exoskeleton Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. ReWalk Robotics Full Body Exoskeleton Product Portfolio Table 103. ReWalk Robotics Recent Development Table 104. Parker Hannifin Company Information Table 105. Parker Hannifin Business Overview Table 106. Parker Hannifin Full Body Exoskeleton Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Parker Hannifin Full Body Exoskeleton Product Portfolio Table 108. Parker Hannifin Recent Development Table 109. Bionik Laboratories Company Information Table 110. Bionik Laboratories Business Overview Table 111. Bionik Laboratories Full Body Exoskeleton Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Bionik Laboratories Full Body Exoskeleton Product Portfolio Table 113. Bionik Laboratories Recent Development Table 114. Rex Bionics Company Information Table 115. Rex Bionics Business Overview Table 116. Rex Bionics Full Body Exoskeleton Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Rex Bionics Full Body Exoskeleton Product Portfolio Table 118. Rex Bionics Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. Full Body Exoskeleton Distributors List Table 122. Full Body Exoskeleton Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Full Body Exoskeleton Product Image Figure 2. Global Full Body Exoskeleton Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Full Body Exoskeleton Sales Value (2021-2032) & (US$ Million) Figure 4. Global Full Body Exoskeleton Sales (2021-2032) & (k units) Figure 5. Global Full Body Exoskeleton Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Full Body Exoskeleton Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Rehabilitation Exoskeleton Image Figure 10. Industrial Exoskeleton Image Figure 11. Military and Defense Exoskeleton Image Figure 12. Sports and Fitness Exoskeleton Image Figure 13. Search and Rescue Exoskeleton Image Figure 14. Global Full Body Exoskeleton Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Full Body Exoskeleton Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Full Body Exoskeleton Sales Volume Share by Type (2021-2032) Figure 17. Global Full Body Exoskeleton Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Full Body Exoskeleton Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Full Body Exoskeleton Sales Value Share by Type (2021-2032) Figure 20. Rehabilitation Image Figure 21. Assistive Image Figure 22. Defense Image Figure 23. Industrial Image Figure 24. Other Image Figure 25. Global Full Body Exoskeleton Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 26. Global Full Body Exoskeleton Sales Volume Share 2021 VS 2025 VS 2032 Figure 27. Global Full Body Exoskeleton Sales Volume Share by Application (2021-2032) Figure 28. Global Full Body Exoskeleton Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Full Body Exoskeleton Sales Value Share 2021 VS 2025 VS 2032 Figure 30. Global Full Body Exoskeleton Sales Value Share by Application (2021-2032) Figure 31. Global Full Body Exoskeleton Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 32. Global Full Body Exoskeleton Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 33. Global Full Body Exoskeleton Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 34. Global Full Body Exoskeleton Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 35. North America Full Body Exoskeleton Sales Value (2021-2032) & (US$ Million) Figure 36. North America Full Body Exoskeleton Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Europe Full Body Exoskeleton Sales Value (2021-2032) & (US$ Million) Figure 38. Europe Full Body Exoskeleton Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Asia-Pacific Full Body Exoskeleton Sales Value (2021-2032) & (US$ Million) Figure 40. Asia-Pacific Full Body Exoskeleton Sales Value Share by Country (%), 2025 VS 2032 Figure 41. South America Full Body Exoskeleton Sales Value (2021-2032) & (US$ Million) Figure 42. South America Full Body Exoskeleton Sales Value Share by Country (%), 2025 VS 2032 Figure 43. Middle East & Africa Full Body Exoskeleton Sales Value (2021-2032) & (US$ Million) Figure 44. Middle East & Africa Full Body Exoskeleton Sales Value Share by Country (%), 2025 VS 2032 Figure 45. USA Full Body Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. USA Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. USA Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Canada Full Body Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Canada Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Canada Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Mexico Full Body Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Mexico Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Mexico Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Germany Full Body Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Germany Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Germany Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. France Full Body Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. France Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. France Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. U.K. Full Body Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. U.K. Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. U.K. Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Italy Full Body Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Italy Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Italy Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Spain Full Body Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Spain Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Spain Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Russia Full Body Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Russia Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Russia Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Netherlands Full Body Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Netherlands Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Netherlands Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Nordic Countries Full Body Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Nordic Countries Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Nordic Countries Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. China Full Body Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. China Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. China Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Japan Full Body Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Japan Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Japan Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. South Korea Full Body Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. South Korea Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. South Korea Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. India Full Body Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. India Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. India Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Australia Full Body Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Australia Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Australia Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Southeast Asia Full Body Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Southeast Asia Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Southeast Asia Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Brazil Full Body Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Brazil Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Brazil Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Argentina Full Body Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Argentina Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Argentina Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Chile Full Body Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Chile Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Chile Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Colombia Full Body Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Colombia Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Colombia Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Peru Full Body Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Peru Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Peru Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Full Body Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Saudi Arabia Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Saudi Arabia Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Israel Full Body Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Israel Arabia Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Israel Arabia Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. UAE Full Body Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. UAE Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. UAE Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Turkey Full Body Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Turkey Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Turkey Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Iran Full Body Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Iran Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Iran Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Egypt Full Body Exoskeleton Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 127. Egypt Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032 & (%) Figure 128. Egypt Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032 & (%) Figure 129. Full Body Exoskeleton Value Chain Figure 130. Manufacturing Cost Structure Figure 131. Full Body Exoskeleton Sales Mode & Process Figure 132. Direct Comparison with Distribution Share Figure 133. Distributors Profiles Figure 134. Years Considered Figure 135. Research Process Figure 136. Key Executives Interviewed

Scope & coverage.

Types
  • Rehabilitation Exoskeleton
  • Industrial Exoskeleton
  • Military and Defense Exoskeleton
  • Sports and Fitness Exoskeleton
  • Search and Rescue Exoskeleton
Applications
  • Rehabilitation
  • Assistive
  • Defense
  • Industrial
  • Other
Companies covered
  • Suit X
  • Cyberdyne
  • B-Temia
  • Wandercraft
  • ExoAtlet
  • Ekso Bionics
  • ReWalk Robotics
  • Parker Hannifin
  • Bionik Laboratories
  • Rex Bionics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Full Body Exoskeleton Sales Value (2021-2032)
  4. 1.2.2 Global Full Body Exoskeleton Sales Volume (2021-2032)
  5. 1.2.3 Global Full Body Exoskeleton Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Full Body Exoskeleton Market Dynamics
  1. 2.1 Full Body Exoskeleton Industry Trends
  2. 2.2 Full Body Exoskeleton Industry Drivers
  3. 2.3 Full Body Exoskeleton Industry Opportunities and Challenges
  4. 2.4 Full Body Exoskeleton Industry Restraints
3 Full Body Exoskeleton Market by Company
  1. 3.1 Global Full Body Exoskeleton Company Revenue Ranking in 2025
  2. 3.2 Global Full Body Exoskeleton Revenue by Company (2021-2026)
  3. 3.3 Global Full Body Exoskeleton Sales Volume by Company (2021-2026)
  4. 3.4 Global Full Body Exoskeleton Average Price by Company (2021-2026)
  5. 3.5 Global Full Body Exoskeleton Company Ranking (2024-2026)
  6. 3.6 Global Full Body Exoskeleton Company Manufacturing Base and Headquarters
  7. 3.7 Global Full Body Exoskeleton Company Product Type and Application
  8. 3.8 Global Full Body Exoskeleton Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Full Body Exoskeleton Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Full Body Exoskeleton Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Full Body Exoskeleton Market by Type
  1. 4.1 Full Body Exoskeleton Type Introduction
  2. 4.1.1 Rehabilitation Exoskeleton
  3. 4.1.2 Industrial Exoskeleton
  4. 4.1.3 Military and Defense Exoskeleton
  5. 4.1.4 Sports and Fitness Exoskeleton
  6. 4.1.5 Search and Rescue Exoskeleton
  7. 4.2 Global Full Body Exoskeleton Sales Volume by Type
  8. 4.2.1 Global Full Body Exoskeleton Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Full Body Exoskeleton Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Full Body Exoskeleton Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Full Body Exoskeleton Sales Value by Type
  12. 4.3.1 Global Full Body Exoskeleton Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Full Body Exoskeleton Sales Value by Type (2021-2032)
  14. 4.3.3 Global Full Body Exoskeleton Sales Value Share by Type (2021-2032)
5 Full Body Exoskeleton Market by Application
  1. 5.1 Full Body Exoskeleton Application Introduction
  2. 5.1.1 Rehabilitation
  3. 5.1.2 Assistive
  4. 5.1.3 Defense
  5. 5.1.4 Industrial
  6. 5.1.5 Other
  7. 5.2 Global Full Body Exoskeleton Sales Volume by Application
  8. 5.2.1 Global Full Body Exoskeleton Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Full Body Exoskeleton Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Full Body Exoskeleton Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Full Body Exoskeleton Sales Value by Application
  12. 5.3.1 Global Full Body Exoskeleton Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Full Body Exoskeleton Sales Value by Application (2021-2032)
  14. 5.3.3 Global Full Body Exoskeleton Sales Value Share by Application (2021-2032)
6 Full Body Exoskeleton Regional Sales and Value Analysis
  1. 6.1 Global Full Body Exoskeleton Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Full Body Exoskeleton Sales by Region (2021-2032)
  3. 6.2.1 Global Full Body Exoskeleton Sales by Region: 2021-2026
  4. 6.2.2 Global Full Body Exoskeleton Sales by Region (2027-2032)
  5. 6.3 Global Full Body Exoskeleton Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Full Body Exoskeleton Sales Value by Region (2021-2032)
  7. 6.4.1 Global Full Body Exoskeleton Sales Value by Region: 2021-2026
  8. 6.4.2 Global Full Body Exoskeleton Sales Value by Region (2027-2032)
  9. 6.5 Global Full Body Exoskeleton Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Full Body Exoskeleton Sales Value (2021-2032)
  12. 6.6.2 North America Full Body Exoskeleton Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Full Body Exoskeleton Sales Value (2021-2032)
  15. 6.7.2 Europe Full Body Exoskeleton Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Full Body Exoskeleton Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Full Body Exoskeleton Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Full Body Exoskeleton Sales Value (2021-2032)
  21. 6.9.2 South America Full Body Exoskeleton Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Full Body Exoskeleton Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Full Body Exoskeleton Sales Value Share by Country, 2025 VS 2032
7 Full Body Exoskeleton Country-level Sales and Value Analysis
  1. 7.1 Global Full Body Exoskeleton Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Full Body Exoskeleton Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Full Body Exoskeleton Sales by Country (2021-2032)
  4. 7.3.1 Global Full Body Exoskeleton Sales by Country (2021-2026)
  5. 7.3.2 Global Full Body Exoskeleton Sales by Country (2027-2032)
  6. 7.4 Global Full Body Exoskeleton Sales Value by Country (2021-2032)
  7. 7.4.1 Global Full Body Exoskeleton Sales Value by Country (2021-2026)
  8. 7.4.2 Global Full Body Exoskeleton Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Full Body Exoskeleton Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Full Body Exoskeleton Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Full Body Exoskeleton Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Full Body Exoskeleton Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Full Body Exoskeleton Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Full Body Exoskeleton Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Full Body Exoskeleton Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Full Body Exoskeleton Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Full Body Exoskeleton Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Full Body Exoskeleton Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Full Body Exoskeleton Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Full Body Exoskeleton Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Full Body Exoskeleton Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Full Body Exoskeleton Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Full Body Exoskeleton Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Full Body Exoskeleton Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Full Body Exoskeleton Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Full Body Exoskeleton Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Full Body Exoskeleton Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Full Body Exoskeleton Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Full Body Exoskeleton Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Full Body Exoskeleton Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Full Body Exoskeleton Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Full Body Exoskeleton Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Full Body Exoskeleton Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Full Body Exoskeleton Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Full Body Exoskeleton Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Full Body Exoskeleton Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Full Body Exoskeleton Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Full Body Exoskeleton Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Suit X
  2. 8.1.1 Suit X Company Information
  3. 8.1.2 Suit X Business Overview
  4. 8.1.3 Suit X Full Body Exoskeleton Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Suit X Full Body Exoskeleton Product Portfolio
  6. 8.1.5 Suit X Recent Developments
  7. 8.2 Cyberdyne
  8. 8.2.1 Cyberdyne Company Information
  9. 8.2.2 Cyberdyne Business Overview
  10. 8.2.3 Cyberdyne Full Body Exoskeleton Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Cyberdyne Full Body Exoskeleton Product Portfolio
  12. 8.2.5 Cyberdyne Recent Developments
  13. 8.3 B-Temia
  14. 8.3.1 B-Temia Company Information
  15. 8.3.2 B-Temia Business Overview
  16. 8.3.3 B-Temia Full Body Exoskeleton Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 B-Temia Full Body Exoskeleton Product Portfolio
  18. 8.3.5 B-Temia Recent Developments
  19. 8.4 Wandercraft
  20. 8.4.1 Wandercraft Company Information
  21. 8.4.2 Wandercraft Business Overview
  22. 8.4.3 Wandercraft Full Body Exoskeleton Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Wandercraft Full Body Exoskeleton Product Portfolio
  24. 8.4.5 Wandercraft Recent Developments
  25. 8.5 ExoAtlet
  26. 8.5.1 ExoAtlet Company Information
  27. 8.5.2 ExoAtlet Business Overview
  28. 8.5.3 ExoAtlet Full Body Exoskeleton Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 ExoAtlet Full Body Exoskeleton Product Portfolio
  30. 8.5.5 ExoAtlet Recent Developments
  31. 8.6 Ekso Bionics
  32. 8.6.1 Ekso Bionics Company Information
  33. 8.6.2 Ekso Bionics Business Overview
  34. 8.6.3 Ekso Bionics Full Body Exoskeleton Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Ekso Bionics Full Body Exoskeleton Product Portfolio
  36. 8.6.5 Ekso Bionics Recent Developments
  37. 8.7 ReWalk Robotics
  38. 8.7.1 ReWalk Robotics Company Information
  39. 8.7.2 ReWalk Robotics Business Overview
  40. 8.7.3 ReWalk Robotics Full Body Exoskeleton Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 ReWalk Robotics Full Body Exoskeleton Product Portfolio
  42. 8.7.5 ReWalk Robotics Recent Developments
  43. 8.8 Parker Hannifin
  44. 8.8.1 Parker Hannifin Company Information
  45. 8.8.2 Parker Hannifin Business Overview
  46. 8.8.3 Parker Hannifin Full Body Exoskeleton Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Parker Hannifin Full Body Exoskeleton Product Portfolio
  48. 8.8.5 Parker Hannifin Recent Developments
  49. 8.9 Bionik Laboratories
  50. 8.9.1 Bionik Laboratories Company Information
  51. 8.9.2 Bionik Laboratories Business Overview
  52. 8.9.3 Bionik Laboratories Full Body Exoskeleton Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Bionik Laboratories Full Body Exoskeleton Product Portfolio
  54. 8.9.5 Bionik Laboratories Recent Developments
  55. 8.10 Rex Bionics
  56. 8.10.1 Rex Bionics Company Information
  57. 8.10.2 Rex Bionics Business Overview
  58. 8.10.3 Rex Bionics Full Body Exoskeleton Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Rex Bionics Full Body Exoskeleton Product Portfolio
  60. 8.10.5 Rex Bionics Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Full Body Exoskeleton Value Chain Analysis
  2. 9.1.1 Full Body Exoskeleton Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Full Body Exoskeleton Sales Mode & Process
  6. 9.2 Full Body Exoskeleton Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Full Body Exoskeleton Distributors
  9. 9.2.3 Full Body Exoskeleton Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst